Form 8-K - Current report:
SEC Accession No. 0001640334-23-000334
Filing Date
2023-03-13
Accepted
2023-03-13 06:17:41
Documents
14
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K artl_8k.htm   iXBRL 8-K 21232
  Complete submission text file 0001640334-23-000334.txt   146665

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA artl-20230310.xsd EX-101.SCH 5735
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20230310_lab.xml EX-101.LAB 15188
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20230310_cal.xml EX-101.CAL 908
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20230310_pre.xml EX-101.PRE 9638
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20230310_def.xml EX-101.DEF 2109
8 EXTRACTED XBRL INSTANCE DOCUMENT artl_8k_htm.xml XML 3709
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38951 | Film No.: 23725618
SIC: 2834 Pharmaceutical Preparations